✦ LIBER ✦

Ten-year follow-up of Southwest Oncology Group 8269: a phase II trial of concomitant cisplatin–etoposide and daily thoracic radiotherapy in limited small-cell lung cancer

✍ Scribed by Thomas, Charles R; Giroux, Dorothy J; Janaki, Lalitha M; Turrisi, Andrew T; Crowley, John J; Taylor, Sarah A; McCracken, J.Dean; Shankir Giri, P.G; Gordon, William; Livingston, Robert B; Gandara, David R

Book ID: 118570497
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 95 KB
Volume: 33
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(01)00181-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-774 Phase II study of cisplatin plus e

P-774 Phase II study of cisplatin plus etoposide with concurrent thoracic radiotherapy (TRT) followed by innotecan plus cisplatin in limited stage small-cell lung cancer (SCLC); A West Japan Thoracic Oncology Group Trial

✍ Kashii, T.; Saito, H.; Negoro, S.; Takada, Y.; Ichinose, Y.; Matsui, K.; Eguchi, 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 149 KB

P-62 Phase II trial of irinotecan plus c

P-62 Phase II trial of irinotecan plus cisplatin after cisplatin plus etoposide and concurrent thoracic radiotherapy (TRT) in small cell lung cancer (SCLC) patients with limited disease: West Japan Thoracic Oncology Group 9902

✍ Ichinose, Yukito; Takada, Yoshiki; Matsui, Kaoru; Bessho, Akihiro; Kudoh, Shinzo 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 187 KB

390 poster Combined chemotherapy of cisp

390 poster Combined chemotherapy of cisplatin and etoposide and twice daily thoracic radiotherapy for limited stage small cell lung cancer: a preliminary report of clinical phase I/II trial

📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 147 KB

A phase II study of cisplatin, etoposide

A phase II study of cisplatin, etoposide, and paclitaxel (PET) with G-CSF in untreated patients with extensive small cell lung cancer: A Southwest Oncology Group trial

✍ Kelly, K; Bunn, P.A; Lovato, L; Crowley, J; Livingston, R.B; Gandara, D.R 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 116 KB

Long term follow-up (F/U) from SWOG 8269

Long term follow-up (F/U) from SWOG 8269: concurrent cisplatin (P), etoposide (E), vincristine (V) and daily thoracic radiotherapy (TRT) for the treatment of limited small-cell lung cancer (LSCLC): patterns of failure and second tumors

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 174 KB

Daily low-dose cisplatin plus concurrent

Daily low-dose cisplatin plus concurrent high-dose thoracic irradiation in locally advanced unresectable non-small-cell lung cancer: Results of a phase II Southwest Oncology Group study

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 150 KB